News

Quantum Computing's Q2 revenues jump to $5.6 million, but rising expenses and continued losses keep profitability a key concern despite ample liquidity.

Each quantum computing company finalized a $100 million R&D agreement with the U.S. Department of Commerce, which will receive a minority stake in each firm

The Commerce Department just took equity stakes in two quantum computing companies, and the fine print on that government ownership may matter more to long-term investors than today's share price pops.

The U.S. government is taking minority equity stakes in D-Wave Quantum, Rigetti Computing, and Quantinuum with a combined $300 million CHIPS Act deal that funds the three companies to scale quantum-computing research.

D-Wave Quantum (NASDAQ:QBTS) shares rose 4. 5% on Tuesday after the quantum computing company announced a definitive agreement with the U.

Rising losses, weak revenue conversion and lofty valuation offset D-Wave Quantum's strong bookings and production adoption, putting the company under pressure.

The U.S. government is committing a combined $300 million to D-Wave Quantum, Rigetti Computing and Quantinuum.

↘️ Amgen (AMGN): Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis (CH:NOVN) said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.

D-Wave Quantum stock has delivered a very large 3 year gain, yet on broad valuation checks it still screens as expensive rather than a clear bargain. The recent share price swings and legal scrutiny give investors a lot to weigh before deciding what that premium means for risk and return. The stock has returned about 17x over 3 years, which puts extra focus on how much future growth is already reflected in the price. Commercial use cases for D-Wave Quantum’s annealing systems can support...

QBTS' commercial momentum is strengthening as QCaaS revenues, bookings, backlog and production adoption rise despite flat quarterly sales.

D-Wave Quantum (QBTS) is back in focus after two law firms announced investigations into potential securities issues, following second quarter revenue that fell short of expectations and the retirement of its Chief Financial Officer. At a share price of $16.82, D-Wave Quantum has seen short term momentum weaken, with the 30 day share price return down 22.95% and the year to date share price return down 40.21%, even though the 3 year total shareholder return is very large. Recent drops around...

D-Wave Quantum Inc. announced that long-time Chief Financial Officer John Markovich retired on September 2, 2026, with senior vice president of finance Greg Golkov stepping in as acting CFO and principal financial and accounting officer. The company emphasized continuity by highlighting that Markovich’s departure did not stem from disagreements and that Golkov has already been overseeing key finance functions, including SEC reporting and financial planning. We’ll now consider how the CFO...

Quantum Computing is betting on higher production volumes and scalable manufacturing as rising costs and gross losses weigh on profitability.

NVIDIA and four tech giants offer quantum exposure through cloud, software and infrastructure, helping investors tap the boom beyond pure plays.

Beyond hardware, Quantum Computing as a Service is emerging as a key revenue driver for D-Wave, Rigetti, and Quantum Computing Inc., with D-Wave appearing best positioned so far.

QUBT and QBTS both face post-earnings weakness, but stronger revenue growth, liquidity and lower valuation give QUBT an edge.

IonQ is growing blisteringly fast.

D-Wave Quantum has paying customers and a broadening technology platform. Here's why that's not the whole story.

Insiders at ​IonQ, Inc. (NYSE:IONQ), ​Rigetti Computing, Inc. (NASDAQ:RGTI), and D-Wave Quantum Inc. (NYSE:QBTS), the three largest pure-play quantum computing companies trading on US markets, have sold approximately $863 million more of their own stock than they have purchased over the last three years combined. The figure, as per an analysis of Form 4 filings […]

D-Wave Quantum shares fell 16.6% this week after CFO John Markovich's surprise retirement rattled investors already uneasy about the quantum computing stock's mounting losses.

Buying the stock today means paying for an engineering roadmap that runs years out, not for the hardware revenue the company books now.

One analyst is overlooking Quantum Computing Inc.’s bizarre corporate history and persistent financial challenges for a surprising reason.

Rigetti fell nearly as far over the same stretch while IBM and Honeywell held up far better, a split narrow enough to locate the move in how the quantum story is priced, not in anything IonQ reported.

A freshly listed quantum company just landed a multimillion-dollar NASA contract that sent its stock surging well past the broader quantum sector, and the reason it stands apart from IonQ, D-Wave, and Rigetti has everything to do with where it makes its money.

The quantum computing pure play plunged after its 2022 debut, but the stock made a spectacular recovery after 2023.

One analyst is overlooking Quantum Computing Inc.’s bizarre corporate history and persistent financial challenges for a surprising reason.

The fair value estimate for D-Wave Quantum has moved from US$36.84 to US$35.24, signaling a modest reset in how analysts are framing upside for the stock. This shift sits against a wider mix of enthusiasm and caution in recent research, where price targets tend to cluster in the US$30 to US$40 range as investors weigh commercial progress against valuation and execution risk. In the sections that follow, you will see how these updated assumptions fit into the broader D-Wave Quantum narrative...

It had some discouraging news to report from the C-Suite.

Despite D-Wave's strengths, Quantinuum looks like a better pick for investors thanks to its sizable cash moat.

A retiring CFO sent D-Wave Quantum shares tumbling while peers like IonQ and Rigetti got caught in the crossfire, raising a bigger question about whether a routine leadership change reveals something deeper about the risks of owning pre-profit quantum names.